Succesfull Bypassing Agent Treatment in Intra Cranial Bleeding Hemophilia A Patient with High Titer Inhibitor: a Case Report
Unram Medical Journal · 2024
DOI: 10.29303/2pgy3571 ↗Kurz gefasst
Fallbericht in der Zeitschrift Unram Medical Journal, 2024. Verfasst von Yudhi Kurniawan.
Abstract (Originalsprache)
Intracranial hemorrhage (ICH) is one of the major bleeding events causing mortality and long-term morbidity in children with hemophilia, especially those who receive on-demand therapy. Children with hemophilia have a greater risk of intracranial hemorrhage (ICH) than the general population, with estimated prevalences of 3.5-4% of neonates, and 3-10% of children over age 1 to 17-year-old with hemophilia.The mortality rate of hemophilia patients with ICH is 20-25%. The development of neutralizing antibodies (inhibitors) against infused factor VIII currently represents the main complication of replacement therapy in patients with severe hemophilia A. Inhibitors, indeed, particularly high-titer inhibitors (>5 BU/mL), greatly complicate the management of bleeding, exposing patients to an increased morbidity and mortality risk, thus representing a significant burden for physicians of Hemophilia Treatment Centers (HTCs). Although bypassing agents (i.e., activated prothrombin complex concentrate [APCC] and recombinant activated factor VII [rFVIIa]) are available for the treatment and prevention of bleeding in inhibitor patients, their efficacy, safety, and cost–benefit outcomes are poorly known in the long term and should be further improved.
Zitieren
APA
Kurniawan, Y. (2024). Succesfull Bypassing Agent Treatment in Intra Cranial Bleeding Hemophilia A Patient with High Titer Inhibitor: a Case Report. Unram Medical Journal. https://doi.org/10.29303/2pgy3571
Vancouver
Kurniawan Y. Succesfull Bypassing Agent Treatment in Intra Cranial Bleeding Hemophilia A Patient with High Titer Inhibitor: a Case Report. Unram Medical Journal. 2024. doi:10.29303/2pgy3571
BibTeX
@article{Kurniawan2024,
author = {Kurniawan, Yudhi},
title = {Succesfull Bypassing Agent Treatment in Intra Cranial Bleeding Hemophilia A Patient with High Titer Inhibitor: a Case Report},
journal = {Unram Medical Journal},
year = {2024},
doi = {10.29303/2pgy3571}
}
EUVIMED